Explore Our Comprehensive Diagnostics and Biotech Industry Research Reports
P
2022
The global solid tumor testing market was valued at $23.8 billion in 2021, and is projected to reach $46.7 billion by 2031, growing at a CAGR of 7% from 2022 to 2031.
Report Code : A04151 | Pages : 225 | Category : Life Sciences
P
2023
North America Solid Tumor Testing Market to showcase promising growth throughout the projection period from 2022 and 2031 owing to increased spending from emerging countries.
Report Code : A103389 | Pages : 126 | Category : Life Sciences
P
2023
Canada Solid Tumor Testing Market size is projected to increase at a lucrative rate during the forecast period. The Canada Solid Tumor Testing Market report covers the drivers, ...
Report Code : A103390 | Pages : 78 | Category : Life Sciences
P
2023
The U.S. Solid Tumor Testing Market achieved significant revenue share in base year of analysis. The U.S. Solid Tumor Testing Market size is expected to account for a considerable growth rate between 2022 to 2031.
Report Code : A103391 | Pages : 78 | Category : Life Sciences
P
2023
Leading players in Mexico Solid Tumor Testing Market are profiled in the report, providing insights on their key strategies, overview and product offerings in the market.
Report Code : A103392 | Pages : 74 | Category : Life Sciences
P
2023
North America region a dominant position in 2031. The market size section covers country-level market size and forecast which also includes the COVID-19 impact.
Report Code : A103393 | Pages : 126 | Category : Life Sciences
P
2023
In market End User, Hospitals holds the largest revenue share during the analysis period and End User is expected to exhibit the highest CAGR over the analysis period.
Report Code : A103394 | Pages : 90 | Category : Life Sciences
P
2023
The report focuses on the major industry players operating in the France Solid Tumor Testing Market and their relative market share. End User segment dominates the France Solid Tumor Testing Market and is expected to retain its dominance throughout the forecast period.
Report Code : A103395 | Pages : 74 | Category : Life Sciences
P
2023
In market End User, Hospitals holds the largest revenue share during the analysis period and End User is expected to exhibit the highest CAGR over the analysis period.
Report Code : A103396 | Pages : 85 | Category : Life Sciences
P
2023
The End User dominated the market with highest revenue share over the analysis period. The section Top Investment Pockets from report provides insights about most lucrative segment for investment in the market.
Report Code : A103397 | Pages : 80 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.